BioSig Technologies (BSGM) - Kapitalizatsiyaning foydaga nisbati

BioSig Technologies, Inc (BSGM) korporativ emblemasi va logotipi

Ushbu GURU.Markets narxlar grafigi Biosig Technologies (BSGM) kompaniyasining narxlar dinamikasini aks ettiradi, bunda separate_pe ko'rsatkichi -7.00 darajasida turibdi. Biosig Technologies inson omili xatolarini minimallashtirish uchun kardiologiya qurilmalarini aniq kalibrlashga mo'ljallangan dasturiy robotlarni joriy etadi. Biroq, biznes sanoat texnologik gigantlarining kuchli bosimi va FDA tartibga soluvchi to'siqlari ostida omon qolishga harakat qilayotgan bir paytda, klinik joriy etilishning sekinligi va kapital yetishmovchilikka duch kelmoqda.

BioSig Technologies (BSGM): Narx-foyda koeffitsiyenti 04.07.2022dan 12.09.2025gacha

Biosig Technologies (BSGM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning umumiy tahlili:BioSig Technologies, Inc. - BSGM
BioSig Technologies ishlab chiqargan mahsulot

P/E koeffitsiyenti biznesning bozor qiymatining uning sof foydasiga nisbatini hisobga olgan holda investitsiyalarning qoplanish muddatini belgilaydi. Kompaniyaning narx-foyda koeffitsiyentini tahlil qilish orqali investor aktivning haqiqiy daromadlariga nisbatan to'langan premiumning miqdorini baholaydi. Ushbu metrika narxlar tebranishlariga va operatsion samaradorlikdagi o'zgarishlarga juda sezgir hisoblanadi. Biosig Technologies (BSGM) uchun ushbu ko'rsatkich kardiologik uskunalar robotlashtirilgan kalibrlashidagi texnologik ustunlikning kapitalizatsiyasini aks ettiradi. Avtomatlashtirilgan signal sinovlarining aniqligi marjalarga va aksiyalarning fundamental qiymatiga bevosita ta'sir ko'rsatadi.

Raqobatdosh kompaniyalar tahlili

dexcom.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori PEN|NOVT - Kapitalizatsiyaning foydaga nisbati|Haemonetics Corp. - Narx-foyda koeffitsiyenti|P/E multiplikatori Inspire Medical Systems Inc INSP|PRCT: Narx-foyda koeffitsiyenti|conmed.com - Bozor narxining sof foydaga nisbati|PLSE: P/E multiplikatori|INMD - Biznesning o‘zini qoplash muddati|PMI (Picard Medical Inc.) - P/E multiplikatori|Narx-foyda koeffitsiyenti Surmodics Inc. (SRDX)|Narx-foyda koeffitsiyenti SENS (Senseonics)|NPCE (neuropace.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Tactile Medical TCMD|SNWV - Narx-foyda koeffitsiyenti|Outset - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Electromed, Inc.|LNSR: P/E multiplikatori|Narx-foyda multiplikatori RCEL|PROF (Profound Medical Corp) - P/E multiplikatori|Baird Medical Corp (BDMD) - Biznesning o‘zini qoplash muddati|P/E multiplikatori EDAP|Narx-foyda koeffitsiyenti apyxmedical.com APYX|P/E multiplikatori ICCM (IceCure Medical)|P/E multiplikatori Pulmonx Corp LUNG|TELA - Narxning foydaga nisbati|CTSO: Narxning foydaga nisbati|SRTS (Sensus Healthcare Corp) - Narx-foyda koeffitsiyenti|Zynex Corp - Kompaniya qiymatining sof foydaga nisbati|ECOR (electroCore Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Vicarious Surgical Corp RBOT|Narxning foydaga nisbati Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|IRIDEX - Narx-foyda koeffitsiyenti|P/E multiplikatori Intelligent Bio Solutions Inc INBS|AINostix - P/E multiplikatori|Biznesning o‘zini qoplash muddati profusa.com PFSA|strataskinsciences.com (SSKN) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati GCTK (glucotrack.com)|Narxning foydaga nisbati NanoVibronix|Narx-foyda koeffitsiyenti Venus Concept Corporation (VERO)|P/E multiplikatori NUWE|AEMD - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Asensus Surgical ASXC|AVGR: Narx-foyda multiplikatori|CUTR: Narx-foyda koeffitsiyenti|Know Labs Corporation - Bozor narxining sof foydaga nisbati|NARI: P/E multiplikatori|NVRO (nevro.com) - Narxning foydaga nisbati|RSLS (ReShape Lifesciences, Inc.) - P/E multiplikatori|Silk Road Medical, Inc. (SILK) - Biznesning o‘zini qoplash muddati